指南与共识免疫规划卫生政策与健康促进

疟疾疫苗实施计划(MVIP)的伦理争议与后续建议

Integrating public health programs and research after the malaria vaccine implementation program (MVIP): Recommendations for next steps.
指南 / 共识 · Vaccine · 2020-09-25

本文围绕WHO疟疾疫苗实施计划(MVIP)的伦理争议,依据2016年CIOMS国际伦理指南进行案例分析。作者认为MVIP包含实质性研究成分,应适用人体研究伦理规范,而现有知情同意和独立伦理审查要求未满足,并可能不符合社会价值要求。建议WHO公开方案、重新伦理审查并加强国际讨论。

要点

  • MVIP包含实质性研究成分,应适用CIOMS人体研究伦理准则。
  • 现有知情同意和独立伦理审查要求未满足,社会价值要求可能不达标。
  • 建议公开MVIP方案、重新伦理审查并让已入组家庭重新知情同意。

核心结论

  • MVIP具有实质性研究成分,应适用人体研究伦理规范,但知情同意和独立伦理审查要求未满足,且可能不符合社会价值要求。

研究设计与样本

  • 依据2016年CIOMS国际伦理指南对MVIP进行案例分析的指南类文献。

主要发现

  • MVIP包含实质性研究成分,应适用CIOMS人体研究伦理准则。
  • 现有知情同意和独立伦理审查要求未满足。
  • 研究可能不符合CIOMS的社会价值要求。

关键数值与推荐

  • 建议WHO公开MVIP流程细节和方案,由相关伦理委员会评估完整方案。
  • 新入组和已入组父母应被告知研究不确定性,并获得真正的同意或拒绝(继续)参与的机会。
  • 应进行社区参与,并根据伦理审查结果尽可能修改MVIP中需要调整的方面。
  • 需开展关于研究与公共卫生项目整合的国际辩论,疫苗实施项目应涉及更广泛的国际伦理界并确保目标人群参与。

临床怎么用

  • 疫苗实施项目若兼具预防和研究目的,应遵循人体研究伦理规范,确保知情同意和独立伦理审查。
  • 项目启动前应公开方案,开展社区参与,并允许目标人群参与设定启动条件。

局限性

  • 本文为案例分析,未提供原始研究数据或系统评价。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In February 2020, international controversy arose about the ethical acceptability of the WHO Malaria Vaccine Implementation Program (MVIP). Whereas some have argued that this program must be seen as research that is not in line with international ethical standards, notably regarding informed consent and local ethical review, some WHO representatives consider the MVIP as a public health implementation program that need not adhere to these standards. METHODS: We performed a case analysis in light of the 2016 CIOMS International Ethical Guidelines for Health-related Research involving Humans. FINDINGS: We argue that the MVIP has a substantial research component, and that it is prudent to therefore apply ethical norms for research involving humans, such as the CIOMS guidelines. Accordingly, we agree that the ethical requirements of informed consent and independent ethical review have not been met. In addition, we are concerned that the study might not meet CIOMS's social value requirement. RECOMMENDATIONS: We urge WHO to release more details about the process that led to the MVIP program and make the MVIP protocol publicly available. The full protocol should be assessed by the relevant ethics committees, new and already enrolled parents should be informed about the uncertainties under investigation and given a real opportunity to consent or refuse (continued) participation, communities should be engaged, and aspects of MVIP that require alteration in light of ethical review should be altered, if possible. Furthermore, in order to improve good ethical practices, it is necessary to engage in international debate regarding the integration of research and public health programs. Procedurally, vaccine implementation programs that combine both prevention and research should involve the wider international ethics community and ensure participation of the target populations in setting the proper conditions for launching such programs.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. van der Graaf R, Macklin R, Rid A, et al. Integrating public health programs and research after the malaria vaccine implementation program (MVIP): Recommendations for next steps. Vaccine. 2020. PMID: 32981780. doi:10.1016/j.vaccine.2020.08.077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。